MWM
GMED icon

Moran Wealth Management’s Globus Medical GMED Stock Holding History

Moran Wealth Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,669
Closed -$495K – 512
2025
Q4 		$495K Sell
5,669
-2,727
-32% -$207K 0.02% 398
2025
Q3 		$481K Sell
8,396
-2,243
-21% -$129K 0.01% 411
2025
Q2 		$628K Sell
10,639
-1,568
-13% -$101K 0.02% 373
2025
Q1 		$894K Sell
12,207
-1,421
-10% -$117K 0.03% 312
2024
Q4 		$1.13M Sell
13,628
-65
-0.5% -$5.13K 0.04% 290
2024
Q3 		$980K Sell
13,693
-900
-6% -$63.5K 0.03% 300
2024
Q2 		$999K Sell
14,593
-71,577
-83% -$4.28M 0.03% 289
2024
Q1 		$4.62M Buy
86,170
+3,267
+4% +$176K 0.15% 182
2023
Q4 		$4.42M Buy
82,903
+708
+0.9% +$34.5K 0.16% 181
2023
Q3 		$4.08M Buy
82,195
+1,068
+1% +$59.7K 0.16% 172
2023
Q2 		$4.83M Sell
81,127
-1,046
-1% -$59.6K 0.18% 158
2023
Q1 		$4.65M Buy
82,173
+6,191
+8% +$397K 0.18% 161
2022
Q4 		$5.64M Buy
+75,982
New +$5.17M 0.21% 136

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Moran Wealth Management's GMED Position: Q1 2026 in Review

Moran Wealth Management sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 5,669 shares — an estimated $495K sold.

Moran Wealth Management first reported a position in GMED in Q4 2022 and held it in 13 quarters. The position peaked at $5.64M in Q4 2022. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Moran Wealth Management reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Moran Wealth Management sold 5,669 Globus Medical shares in Q1 2026, an estimated $495K.
  • Moran Wealth Management first reported a position in Globus Medical in Q4 2022 and held it in 13 quarters.
  • Moran Wealth Management's Globus Medical position peaked at $5.64M in Q4 2022.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Moran Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.